Sanara Medtech Inc (SMTI) Hedge Fund & Institutional Holdings (Q2 2026)

SMTI ranks #5166 out of 37503 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

SMTI is a disclosed holding of Cliff Asness (AQR Capital Management), one of the tracked superinvestors on AlphaSMO — it makes up 0.0% of that fund's own 13F portfolio.

77 institutions disclose a position in SMTI, but none treat it as a major bet — even Stonebridge Wealth Management, LLC, its most concentrated holder, allocates just 2.7% of its own portfolio to it.

Jane Street Group, LLC has added to its SMTI position for two straight quarters, increasing it by $843.2K to reach $1.2M today.

UBS Group AG has trimmed its SMTI position for two straight quarters, cutting it by $214.6K while still holding $8.4K.

SMTI is up 0.9% today, and institutions have been net buyers of $7.8M this quarter — today's price move and the underlying institutional flow are pointing the same direction.

SMTI reported a net loss of $32.0M over the trailing twelve months.

• Not yet profitable — net loss of $32.0M over the trailing twelve months
• Revenue grew 13.0% year over year
• Net income declined year over year, from -$9.9M to -$32.0M
• Generated $6.8M in positive operating cash flow
• Current ratio of 1.80x — enough short-term assets to cover short-term liabilities
• Liabilities run 7489.30x equity — a highly leveraged balance sheet worth noting